Are patients with non‐muscle‐invasive bladder cancer a suitable population for a lung cancer screening trial?

Abstract

We consider that an annual examination for the detection and prevention of lung cancer must be included in clinical guides for patients with NMIBC. This proposal is reinforced by the finding that death in our group of patients with both tumours was always derived from lung cancer and not from bladder cancer.